Impact of antithrombotic therapy on postpancreatectomy hemorrhage in 7116 patients: A project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Kota NakamuraMinako NagaiIppei MatsumotoSohei SatoiFuyuhiko MotoiManabu KawaiYasuo HosouchiRyota HiguchiShugo MizunoTakao OhtsukaKeiichi AkahoshiKenichi HakamadaMichiaki UnnoHiroki YamaueMasafumi NakamuraItraru EndoMasayuki ShoPublished in: Journal of hepato-biliary-pancreatic sciences (2023)
This multicenter study demonstrated that a history of antithrombotic use was a significant risk factor for PPH and mortality. In particular, the resumption of antithrombotic therapy in the early postoperative period should be done with caution.
Keyphrases
- atrial fibrillation
- end stage renal disease
- newly diagnosed
- minimally invasive
- ejection fraction
- chronic kidney disease
- patients undergoing
- prognostic factors
- peritoneal dialysis
- cardiovascular events
- stem cells
- coronary artery bypass
- cardiovascular disease
- coronary artery disease
- risk factors
- type diabetes
- patient reported outcomes
- acute coronary syndrome
- surgical site infection